BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 8729984)

  • 21. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
    Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
    Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.
    Loy TS; Calaluce RD
    Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jejunal adenocarcinoma presenting as a primary ovarian carcinoma.
    Kilic G; Abadi M
    Gynecol Oncol; 2000 Aug; 78(2):255-8. PubMed ID: 10926813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
    Dai L; Song Q; Li L; Zhong D; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
    Cao D; Ji H; Ronnett BM
    Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma.
    McKinney CD; Mills SE; Franquemont DW
    Mod Pathol; 1995 May; 8(4):421-6. PubMed ID: 7567943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas.
    Multhaupt HA; Arenas-Elliott CP; Warhol MJ
    Arch Pathol Lab Med; 1999 Oct; 123(10):909-16. PubMed ID: 10506443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.
    Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H
    Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
    Gogate N; Deshmukh S
    Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies.
    Debus E; Moll R; Franke WW; Weber K; Osborn M
    Am J Pathol; 1984 Jan; 114(1):121-30. PubMed ID: 6197886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
    Goldstein NS; Thomas M
    Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.